Unknown

Dataset Information

0

High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.

ABSTRACT:

SUBMITTER: Decroo T 

PROVIDER: S-EPMC7301730 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Reply to Decroo <i>et al.</i>: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.
| S-EPMC7301745 | biostudies-literature
Unknown Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosis.
| S-EPMC6783589 | biostudies-literature
Unknown Injectables' key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes.
| S-EPMC7458281 | biostudies-literature
Unknown High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea.
| S-EPMC4930811 | biostudies-literature
Unknown Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.
| S-EPMC4311815 | biostudies-other
Unknown High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre.
| S-EPMC6417786 | biostudies-literature
Unknown High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.
| S-EPMC3511527 | biostudies-other
Unknown Adherence and Associated Factors of Treatment Regimen in Drug-Susceptible Tuberculosis Patients.
| S-EPMC8005597 | biostudies-literature
Unknown Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
| S-EPMC5815623 | biostudies-literature
Unknown Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
| S-EPMC6021677 | biostudies-literature